Robert R. Banks Jr. - Aug 14, 2023 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
President and CEO, Director
Signature
/s/ Edward Peilen as attorney-in-fact for Robert R. Banks, Jr. pursuant to power of attorney filed herewith.
Stock symbol
NEPH
Transactions as of
Aug 14, 2023
Transactions value $
$3,355
Form type
4
Date filed
8/15/2023, 05:15 PM
Previous filing
May 17, 2023
Next filing
Dec 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEPH Common Stock Purchase $149 +99 $1.50 99 Aug 14, 2023 Direct
transaction NEPH Common Stock Purchase $3.21K +1.9K +1920.2% $1.69 2K Aug 15, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEPH Stock Option (right to buy) 357K Aug 14, 2023 Common Stock 357K $1.44 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.66 to $1.73, inclusive. The reporting person undertakes to provide Nephros Inc., any security holder of Nephros Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the set range set forth in this footnote.
F2 Options to purchase 89,291 shares vest on 5/5/24 and options to purchase 267,874 shares vest quarterly in 12 equal amounts commencing on 8/5/24.